Development of Evaluation Indicators for Hospice and Palliative Care Professionals Training Programs in Korea

Kang, Jina; Park, Kyoung-Ok

doi:10.1097/ceh.0000000000000142

Cited by 5 publications

(2 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Other methodologies have been developed and used for evaluation of training programs, but which were not adapted to the PASODOBLEDEMI study. For instance, the Context-Inputs-Process-Product model (or the Stufflebeam model) [ 31 , 32 ] is based on the comparison of pre- and posttraining program evaluation to assess the gain in knowledge and confidence of participants; the Levels of Learning model (or the Kaufman model) is based on the use of specific evaluation scales (Kaufman Test of Educational Achievement) as an individually administered battery that provides in-depth assessment and evaluation of skills [ 33 ], but the design of this model is too rigid for the objectives of this study; and the Success Case Method (or the Brinkerhoff model) that is closer to an economically oriented performance scale with a study design based on a survey and semistructured interviews [ 34 ].…”

Section: Discussionmentioning

confidence: 99%

Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick Model

Fraticelli¹,

Freyssenge²,

Promé-Combel³

et al. 2023

JMIR Res Protoc

View full text Add to dashboard Cite

Background Commercialized since 2019, emicizumab (Hemlibra) was available only in French hospital pharmacies for prophylaxis of hemophilia A with or without inhibitors. Since June 15, 2021, patients can choose between a hospital and community pharmacy. These changes in the care pathway have important organizational consequences for patients, their relatives, and health professionals. Two training programs are available for community pharmacists: the “HEMOPHAR” training program proposed by the national reference center for hemophilia and the Roche training program proposed by the laboratory that markets the product. Objective The PASODOBLEDEMI study aims to evaluate the direct impact of the training programs provided to community pharmacists in the context of the dispensing of emicizumab, and to evaluate patients’ satisfaction with their treatment whether they choose dispensation from a community pharmacy or retained dispensation from the hospital pharmacy. Methods We designed a cross-sectional study based on the 4-level Kirkpatrick evaluation model: the immediate reaction of community pharmacists following training (Reaction), the knowledge acquired during the training (Learning), the professional practice of community pharmacists during dispensing of the product (Behavior), and patients’ satisfaction related to the treatment whether it is dispensed from a hospital or from a community pharmacy (Results). Results Considering that single outcome measures cannot adequately reflect the complexity of this new organization, the Kirkpatrick evaluation model provides 4 distinct outcomes: the immediate reaction after the HEMOPHAR training program, the level of knowledge acquired after the HEMOPHAR training program, the impact of training on professional practice, and patient satisfaction with access to emicizumab. We developed specialized questionnaires for each of the 4 levels of the Kirkpatrick evaluation model. All community pharmacists involved in dispensing emicizumab, whether they have followed the HEMOPHAR or the Roche training program or neither, were eligible for inclusion. All patients with severe hemophilia A were eligible, irrespective of inhibitor use, age, treatment with emicizumab, and whether they chose dispensation from a community pharmacy or retained dispensation from a hospital pharmacy. Conclusions The new organization for dispensing emicizumab to patients with hemophilia A in French community pharmacies must be accompanied by optimal safety and quality conditions due to the risk of serious and urgent bleeding situations in the management of rare bleeding diseases. The elaboration of the PASODOBLEDEMI protocol has already a positive impact with the commitment of all health professionals, physicians, hospital and community pharmacists, and the patient community. The results will be disseminated among the French authorities and will enable, if necessary, proposing this access model to other rare diseases. Trial Registration ClinicalTrials.gov NCT05449197, https://clinicaltrials.gov/ct2/show/NCT05449197?term=NCT05449197; ClinicalTrials.gov NCT05450640, https://clinicaltrials.gov/ct2/show/NCT05450640?term=NCT05450640 International Registered Report Identifier (IRRID) DERR1-10.2196/43091

show abstract

Section: Discussionmentioning

confidence: 99%

Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick Model

Fraticelli¹,

Freyssenge²,

Promé-Combel³

et al. 2023

JMIR Res Protoc

View full text Add to dashboard Cite

show abstract

“…Assessment of the education and training process has become a common practice in many fields of professional activities, and complex methods are used to do that. The CIPP method (contextinputprocessproduct) is pointed out as being universally acceptable for assessing the quality in the terms of construct validity of education programmes in many different fields, adjusting it to the area specifics [12]. In this case, exploratory factor analysis and confirmatory factor analysis may be used to identify the desirable training subjects.…”

Section: Background and Literaturementioning

confidence: 99%

A Comprehensive Methodology for Assessing the Quality of Landscape Architecture Study Programmes in European Higher Education Institutions

Stauskis¹,

Vries²

2018

LAA

View full text Add to dashboard Cite

In the light of recent environmental and socioeconomic challenges that face the modern urban regions, the implication of current needs for education quality has been discussed. Now a further step for practical actions of reshaping higher education in Europe takes place. The quality of teaching of landscape architects has a direct impact on the quality of the professional services and their contribution to design, planning and management of urban open spaces, heritage sites and objects, parks and gardens and (green) infrastructure. A wide variety of landscape architecture (LA) study programmes across Europe provide education that differ in scope, content and quality. Two European landscape associations-the European Council of Landscape Architecture Schools [4] and the International Federation of Landscape Architects (IFLA) Europe developed guidelines for landscape architect's education that covers environmental, engineering and artistic competences and soft skills [4] (IFLA 2008). For IFLA the requirements are a tool for the professional recognition of the programmes. The ECLAS Guidance report (2010) focuses on the core, subject-specific and generic competences that students should acquire in the education process. This framework with requirements, recommendations and guidelines for LA studies aims to increase the quality of the current landscape architecture studies; beyond that, it is used to develop a common tool for assessing the quality of landscape architecture education at several universities in Europe. The results of the assessment reveal the strengths and the gaps of the analysed study programmes and teaching subjects. The outcomes of this inquiry give a clear picture for the schools which study modules and courses should be improved and how to meet the common requirements. At the same time, the method is used to keep and further develop the strong sides of the study programme at each university. Looking at the bigger picture of LA education in Europe, the map of subject-specific competences in landscape architecture training is further developed, by adding cutting-edge competences that are proposed by the participating universities and professional associations.

show abstract

Palliative Care Development in the Asia Pacific Region: A Review of Assessment Indicators

Liu

Montayre

et al. 2021

Journal of Pain and Symptom Management

View full text Add to dashboard Cite

Development of Evaluation Indicators for Hospice and Palliative Care Professionals Training Programs in Korea

Abstract: The evaluation indicators of the modified model will be valuable references for improving the HPC professional training program.

Cited by 5 publications

References 21 publications

Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick Model

Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick Model

A Comprehensive Methodology for Assessing the Quality of Landscape Architecture Study Programmes in European Higher Education Institutions

Palliative Care Development in the Asia Pacific Region: A Review of Assessment Indicators

Contact Info

Product

Resources

About